Tushar Misra
2021
Compensation breakdown
Non-Equity Incentive Plan | $93,147 |
---|---|
Option Awards | $906,323 |
Salary | $161,282 |
Stock Awards | $289,000 |
Other | $5,667 |
Total | $1,455,418 |
Misra received $906.3K in option awards, accounting for 62% of the total pay in 2021.
Misra also received $93.1K in non-equity incentive plan, $161.3K in salary, $289K in stock awards and $5.7K in other compensation.
Rankings
In 2021, Tushar Misra's compensation ranked 7,379th out of 12,415 executives tracked by ExecPay. In other words, Misra earned more than 40.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,379 | 41st |
Manufacturing | 3,243 | 41st |
Chemicals And Allied Products | 1,436 | 40th |
Drugs | 1,279 | 39th |
Pharmaceutical Preparations | 940 | 39th |
Pay ratio
Tushar Misra's Pay | $1,455,418 |
---|---|
Median Employee's Pay | $302,642 |
Pay Ratio | 5to 1 |
In 2021, the annual total compensation of Tushar Misra was $1,455,418.
The annual total compensation of the median employee at Mersana Therapeutics was $302,642.
The ratio of Tushar Misra's pay to the pay of median employee was therefore 5 to one.
Misra's colleagues
We found six more compensation records of executives who worked with Tushar Misra at Mersana Therapeutics in 2021.
2021
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2021
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2021
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2021
Michael Kaufman
Mersana Therapeutics
Former Chief Manufacturing Officer
2021
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
2021
Arvin Yang
Mersana Therapeutics